WHO: No weight-loss medicines, bariatric surgery or weight-loss devices for kids


By AGENCY
The potential of weight-loss medicines for obese children has remained a point of debate until now. Photo: Markus Scholz/dpa

The World Health Organisation (WHO) has issued its first-ever global guidelines for managing childhood obesity.

Released on Oct 7, the guidelines recommend a range of measures to manage obesity, including healthier diets, more physical activity and changes in daily habits. Digital health programmes are also conditionally recommended, but only with supervision from parents or caregivers.

Most importantly, WHO does not recommend weight-loss medicines, bariatric surgery or weight-loss devices for children aged zero to nine.

For teenagers aged 10 to 19, approved weight-loss medicines may be considered only if a supervised programme combining diet, exercise and behavioural changes does not produce the desired results. Bariatric surgery may also be considered in certain cases of severe obesity, but only under strict conditions.

The guidelines also stress the importance of addressing mental health alongside obesity treatment. Anxiety, depression, low self-esteem and difficulty managing emotions can lead to unhealthy eating, less physical activity and social withdrawal.

Children and teenagers with obesity may also face stigma and bullying, which can affect their emotional well-being.

Health workers are advised to address obesity and mental health problems early and together, while involving families and using approaches suited to the child’s age and needs.

WHO says obesity treatment should focus on more than just losing weight. The goal should be to improve a child’s overall health, daily functioning and well-being. Care should be tailored to each child and family, with regular follow-up and long-term support.

WHO also notes that treatment alone cannot stop the global rise in childhood obesity. Governments need to make healthy food and physical activity more affordable and accessible through measures covering areas such as education, urban planning, transport and social protection.

Health experts in Germany had previously said that approved GLP-1 medicines could be considered for some children with obesity only as a supplement to a supervised lifestyle programme, but cautioned that the long-term effects remain unclear. – dpa

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Family

Spending time alone is important, but beware of the shift into social withdrawal
Studies show that smoking cigarettes can affect fertility in both men and women
Study: Using a type of painkiller while pregnant may affect daughters' fertility
As mums juggle work and family, AI apps are becoming their 'second brain'
Study finds that adults with a parent who lived to 100 have lower health risks
No risk of birth complication for pregnant women on weight loss medication
It's never too late to start exercising and strength-training
How divorced parents can celebrate their child's birthday in a healthy way
Helpful co-parenting tips for raising happy kids across separate households
New research finds that parents are still supporting their adult kids' finances

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read